Projects funded by the NCN

Patient-specific iPS cells as a novel approach to study patophysiology of mTOR-related neurodevelopmental disorders

Call: SONATA 6 , Panel: NZ3

Principal investigator: dr Ewa Liszewska

Międzynarodowy Instytut Biologii Molekularnej i Komórkowej

New mechanisms of cellular reprogramming: role of TLR3 and RIG-1 activation and downstream anti-inflammatory response to...

Call: PRELUDIUM 6 , Panel: NZ1

Principal investigator: dr Jacek Stępniewski

Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

Studies of efficacy of microvesicles derived from genetically modified stem cells as carriers for proangiogenic and card...

Call: SONATA BIS 3 , Panel: NZ3

Principal investigator: dr hab. Ewa Zuba-Surma

Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

Inducible pluripotent stem cells as a tool in articular cartilage regeneration.

Call: SONATA BIS 2 , Panel: NZ3

Principal investigator: dr Wiktoria Suchorska

Wielkopolskie Centrum Onkologii

Development of an innovative method of preparing iPS cells for gene-cell therapy of hereditary diseases based on the Ost...

Call: PRELUDIUM 19 , Panel: NZ2

Principal investigator: Agnieszka Fus-Kujawa

Śląski Uniwersytet Medyczny w Katowicach, Wydział Nauk Medycznych w Katowicach

Analysis of intracellular mechanisms regulating transgene expression from AAV vectors of various serotypes

Call: PRELUDIUM 17 , Panel: NZ1

Principal investigator: Izabela Kraszewska

Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

Significance of transcription factors associated with epithelial-mesenchymal transition and myogenesis in the developmen...

Call: OPUS 15 , Panel: NZ5

Principal investigator: prof. Marcin Majka

Uniwersytet Jagielloński – Collegium Medicum, Collegium Medicum, Wydział Lekarski

Embryotoxicity and teratogenicity as a result of response to DNA damage in iPS cells: the effect of methylmercury chlori...

Call: PRELUDIUM 9 , Panel: NZ7

Principal investigator: Justyna Augustyniak

Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN